Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-15

Clinical Trial Update: Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update assessing the safety and efficacy of HDM1002 tablets in overweight and obese adults, with the study currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDM1002 (HDM1002)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Overweight and Obesity | Phase 2 | Status: NOT_YET_RECRUITING